Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
Track This Opportunity
Create an account to track opportunities.
About This Opportunity
This is a federal grant from the National Institutes of Health (NIH) for researchers and businesses focused on developing and validating new technologies for basic and clinical cancer research. Recipients receive funding to advance innovative tools and methods, specifically for projects that do not involve clinical trials.
Eligibility Requirements
Application Guide
Scientific merit, innovation, investigator qualifications, research environment, and potential impact on cancer research.
Carefully read the full funding announcement (RFA/PA), clearly articulate the scientific premise and innovation, and ensure all required sections and attachments are complete and compliant with NIH guidelines.
Geographic Coverage
Links & Resources
Source & freshness
Last verified: 8/12/2026
Primary source: Official source page
Refresh cadence: Listings are refreshed weekly.
Reminder: Confirm eligibility and deadlines before applying.